Journal Article10.1111/tra.12840
Extracellular 20S proteasome secreted via microvesicles can degrade poorly folded proteins and inhibit Galectin‐3 agglutination activity
Anne Bonhoure,Laurent Henry,Claudia Bich,Lionel Blanc,Blanche Bergeret,Marie-Pierre Bousquet,Olivier Coux,P.-E. Stoebner,Michel Vidal +8 more
TL;DR: It is demonstrated that assembled 20S core particles are secreted by cells within microvesicles budding from the plasma membrane, and this free proteasome released by cells possesses latent proteolytic activity and can degrade various extracellular proteins.
read more
Abstract: Proteasomes are major non‐lysosomal proteolytic complexes localized in the cytoplasm and in the nucleus of eukaryotic cells. Strikingly, high levels of extracellular proteasome have also been evidenced in the plasma (p‐proteasome) of patients with specific diseases. Here, we examined the process by which proteasomes are secreted, as well as their structural and functional features once in the extracellular space. We demonstrate that assembled 20S core particles are secreted by cells within microvesicles budding from the plasma membrane. Part of the extracellular proteasome pool is also free of membranes in the supernatant of cultured cells, and likely originates from microvesicles leakage. We further demonstrate that this free proteasome released by cells (cc‐proteasome for cell culture proteasome) possesses latent proteolytic activity and can degrade various extracellular proteins. Both standard (no immune‐subunits) and intermediate (containing some immune‐subunits) forms of 20S are observed. Moreover, we show that galectin‐3, which displays a highly disordered N‐terminal region, is efficiently cleaved by purified cc‐proteasome, without SDS activation, likely after its binding to PSMA3 (α7) subunit through its intrinsically disordered region. As a consequence, galectin‐3 is unable to induce red blood cells agglutination when preincubated with cc‐proteasome. These results highlight potential novel physio‐ and pathologic functions for the extracellular proteasome.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
References
Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers
TL;DR: New and improved strategies for microvesicle identification, isolation, and capture will have marked implications in point-of-care diagnostics for cancer patients.
Biology and biogenesis of shed microvesicles.
TL;DR: Current status of the rapidly evolving field of microvesicle biology is reviewed, highlighting critical regulatory roles for several small GTPases in the biology and biogenesis of shed microvesicles.
506
Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival.
María T. Elola,Carlota Wolfenstein-Todel,María F. Troncoso,Gerardo R. Vasta,Gabriel A. Rabinovich +4 more
TL;DR: These intriguing glycan-binding proteins offer promising possibilities for the treatment and intervention of a wide variety of pathological processes, including cancer, inflammation, and autoimmunity.
378
Extracellular α-synuclein—a novel and crucial factor in Lewy body diseases
TL;DR: A rapidly growing body of literature on possible mechanisms by which extracellular α-synuclein contributes to LBD pathology is reviewed, and therapeutic approaches to target this form of α- synuclein to halt disease progression are discussed.
297
Release of diacylglycerol-enriched vesicles from erythrocytes with increased intracellular (Ca2+)
TL;DR: In these experiments, it seemed that microvesicles budded off from the microvillus-like projections on the echinocytes, and were isolated and examined their composition and structure.
246